Study finds weakness in drug-resistant tuberculosis pathogens

A University of Otago-led study has found highly vulnerable weakness in drug-resistant Mycobacterium tuberculosis, offering a new way to kill them.

Study challenges health benefits of artificially sweetened beverages, links to increased health risks

An umbrella review in Advances in Nutrition, examining previous systematic reviews and meta-analyses, reveals that regular consumption of artificially sweetened beverages (ASBs) is associated with

November 16, 2023

New AI tool revolutionizes drug discovery for rare diseases

There are more than 7,000 rare and undiagnosed diseases globally.

September 25, 2024

BridgeBio raises up to $1.2B, a month after submitting cardio drug to FDA

BridgeBio has tapped investors for up to $1.25 billion as it prepares to commercialize its heart pill and get some breathing room to continue running

January 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.